Even with recent advances in cancer diagnosis and therapy, treatment outcomes for
many cancers remain dismal. Patients often show different response to the same therapy
regimen, supporting the development of personalized medicine. 18F-FDG PET/CT has been used
routinely in the assessment of tumor response, in prediction of outcomes, and in guiding
personalized treatment. These assessments are mainly based on physician’s
subjective or semi-quantitative evaluation. Recent development in Radiomics provides a
scite is a Brooklyn-based startup that helps researchers better discover and evaluate scientific articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by researchers from dozens of countries and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.